Glenmark Pharmaceuticals Launches Vancomycin for Injection USP in US
Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP in the US market, expanding its injectable portfolio in a segment valued at nearly USD 37.9 million annually.
Sterile Injectable Medicines | 18/05/2026 | By News Bureau
Delpharm to Advance its Sterile Injectable Manufacturing Facility in Boucherville
The signing of a 10-year agreement between Delpharm and Sandoz establishes a foundation for ensuring a stable and reliable supply of critical medicines for Canadians, thereby enhancing the country's healthcare autonomy amid global supply chain disruptions.
Sterile Injectable Medicines | 19/03/2025 | By Aishwarya | 316
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy